Driver safety in patients with primary brain tumors

被引:4
|
作者
Estevis, Eduardo [1 ]
Noll, Kyle R. [2 ]
Bradshaw, Mariana E. [2 ]
Wefel, Jeffrey S. [2 ,3 ]
机构
[1] DHR Hlth, Neurosci Inst, Edinburg, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, 1515 Holcombe Blvd,Unit 431, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
brain tumor; cancer; driving; neuropsychological function; DRIVING PERFORMANCE; OLDER DRIVERS; DEMENTIA; INVENTORY; SIMULATOR; VALIDITY; DEFICITS; IMPACT; GLIOMA; ADULTS;
D O I
10.1093/nop/npz014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background. Operating a motor vehicle involves multiple cognitive and sensorimotor faculties. Neurological conditions pose driving risk, but this has not been examined in patients with primary brain tumors. Methods. Sixty-four patients with primary brain tumors (32 left hemisphere; 69% glioblastoma) completed the Cognitive Behavioral Driver's Inventory (CBDI). A subset also completed broader cognitive testing. Patient characteristics, CBDI measures, and broader neuropsychological test scores were compared between Passing and Nonpassing groups. Follow-up logistic regression analyses identified patient characteristics and CBDI measures predictive of Pass/Nonpass outcome. Point-biserial correlations determined associations between neuropsychological tests and CBDI outcome. Results. Sixty-nine percent of patients were classified as passing the CBDI. Nonpassing patients were older and more likely to have WHO grade IV and temporal lobe tumors. Age was the most salient predictor of CBDI performance. CBDI measures of speeded visual search and set-shifting, speeded response inhibition, vigilance and freedom from distractibility, and basic visual scanning speed were predictive of Pass/Nonpass outcome. Neuropsychological tests of memory in particular, but also speeded visual scanning and discrimination, executive function, basic visual attention, visuoconstruction, and manual dexterity (dominant hand), were associated with CBDI outcome. Conclusions. A sizeable proportion of patients with primary brain tumors appear at risk of driving difficulty, particularly those with higher-grade tumors and of older age. Memory, visual attention, and executive difficulties appear to contribute most to driving safety risk as determined by the CBDI. These results highlight the importance of driving safety screening in this population.
引用
收藏
页码:490 / 498
页数:9
相关论文
共 50 条
  • [31] Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors
    Martha M. Kirstein
    Steffen Marquardt
    Nils Jedicke
    Silke Marhenke
    Wolfgang Koppert
    Michael P. Manns
    Frank Wacker
    Arndt Vogel
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 2113 - 2121
  • [32] Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors
    Kirstein, Martha M.
    Marquardt, Steffen
    Jedicke, Nils
    Marhenke, Silke
    Koppert, Wolfgang
    Manns, Michael P.
    Wacker, Frank
    Vogel, Arndt
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (10) : 2113 - 2121
  • [33] Patient Safety Concerns for Cognitively Impaired Patients With Brain Tumors
    Doherty, Lisa
    LaFrankie, Debra Conrad
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2010, 14 (01) : 101 - 102
  • [34] Safety of commercial airflight in patients with brain tumors: a case series
    Michelle Phillips
    Marlon Saria
    Amy Eisenberg
    Daniel F. Kelly
    Garni Barkhoudarian
    Journal of Neuro-Oncology, 2018, 139 : 617 - 623
  • [35] SAFETY OF COMMERCIAL AIRFLIGHT IN PATIENTS WITH BRAIN TUMORS - A CASE SERIES
    Phillips, Michelle
    Saria, Marlon Garzo
    Eisenberg, Amy
    Kelly, Daniel
    Barkhoudarian, Garni
    NEURO-ONCOLOGY, 2017, 19 : 109 - 110
  • [36] Safety of commercial airflight in patients with brain tumors: a case series
    Phillips, Michelle
    Saria, Marlon
    Eisenberg, Amy
    Kelly, Daniel F.
    Barkhoudarian, Garni
    JOURNAL OF NEURO-ONCOLOGY, 2018, 139 (03) : 617 - 623
  • [37] IMMUNOBIOLOGY OF PRIMARY INTRACRANIAL TUMORS .2. ANALYSIS OF LYMPHOCYTE SUBPOPULATIONS IN PATIENTS WITH PRIMARY BRAIN TUMORS
    BROOKS, WH
    ROSZMAN, TL
    MAHALEY, MS
    WOOSLEY, RE
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1977, 29 (01): : 61 - 66
  • [38] Recurrent Stroke after Silent Brain Infarction in Patients with Primary Brain Tumors
    Parikh, Neal
    Burch, Jaclyn
    Kamel, Hooman
    DeAngelis, Lisa
    Navi, Babak
    NEUROLOGY, 2017, 88
  • [39] Efficacy of postacute brain injury rehabilitation for patients with primary malignant brain tumors
    Sherer, M
    Meyers, CA
    Bergloff, P
    CANCER, 1997, 80 (02) : 250 - 257
  • [40] Disparities in place of death for patients with primary brain tumors and brain metastases in the USA
    Shenker, Rachel F.
    McLaughlin, Mary Elizabeth
    Chino, Fumiko
    Chino, Junzo
    SUPPORTIVE CARE IN CANCER, 2022, 30 (08) : 6795 - 6805